FDA allows Houston cancer doctor to resume drug trial
Por um escritor misterioso
Descrição
Federal regulators have lifted a partial hold on a clinical trial performed by Stanislaw
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial - The Lancet Oncology
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Oncology
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study - The Lancet Oncology
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
Structure-based classification predicts drug response in EGFR-mutant NSCLC
Funda Meric-Bernstam MD Anderson Cancer Center
Ashish M. Kamat MD Anderson Cancer Center
Recent Targeted Therapies Approved for the Treatment of Patients with Urothelial Carcinoma
Doctor claims to cure pediatric cancer, critics skeptical
James P. Allison, Ph.D., Immunotherapy Researcher
de
por adulto (o preço varia de acordo com o tamanho do grupo)
